This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Smithkline Beecham Biologicals S.a.. Active years: 2003-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Genval, BE (2003 - 2005)
- Rixensart, BE (2007 - 2010)
Company Filing History:
3 out of 545 
3 out of 75 Years Active: 2003-2010
Title: Brigitte Desiree Alberte Colau: Innovator in Rotavirus Vaccine Development
Introduction
Brigitte Desiree Alberte Colau is a notable inventor based in Rixensart, Belgium. She has made significant contributions to the field of vaccine development, particularly in the area of rotavirus. With a total of six patents to her name, Colau's work has the potential to impact public health positively.
Latest Patents
Colau's latest patents include innovations related to a homogeneous attenuated human rotavirus population. One of her inventions provides an attenuated rotavirus population comprising a single variant, defined by a nucleotide sequence encoding major viral proteins designated as VP4 and VP7. This invention particularly highlights a rotavirus population designated as P43. Additionally, she has developed a novel formulation for a rotavirus vaccine, which is designed as a quick-dissolving tablet for immediate dissolution when placed on the tongue. Another patent focuses on the immunogenic composition of a homogeneous live attenuated human rotavirus population, reiterating the significance of the P43 variant and the innovative tablet formulation.
Career Highlights
Throughout her career, Colau has worked with prominent companies in the pharmaceutical industry, including GlaxoSmithKline Biologicals SA and SmithKline Beecham Biologicals S.A. Her experience in these organizations has contributed to her expertise in vaccine research and development.
Collaborations
Colau has collaborated with notable colleagues such as Francoise Denamur and Isabelle Knott. These partnerships have likely enhanced her research efforts and contributed to her successful patent applications.
Conclusion
Brigitte Desiree Alberte Colau is a pioneering inventor whose work in rotavirus vaccine development showcases her commitment to improving public health. Her innovative patents and collaborations reflect her significant contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile